Aspiriant LLC’s Capital One COF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.16M | Buy |
5,766
+1,043
| +22% | +$200K | 0.03% | 161 |
|
|
2026
Q1 | $862K | Sell |
4,723
-234
| -5% | -$48.9K | 0.02% | 165 |
|
|
2025
Q4 | $1.2M | Buy |
4,957
+844
| +21% | +$188K | 0.03% | 149 |
|
|
2025
Q3 | $874K | Buy |
4,113
+335
| +9% | +$73.3K | 0.03% | 156 |
|
|
2025
Q2 | $804K | Buy |
3,778
+867
| +30% | +$162K | 0.03% | 163 |
|
|
2025
Q1 | $522K | Buy |
2,911
+67
| +2% | +$12.7K | 0.02% | 188 |
|
|
2024
Q4 | $507K | Buy |
2,844
+201
| +8% | +$34.8K | 0.02% | 187 |
|
|
2024
Q3 | $396K | Sell |
2,643
-266
| -9% | -$37.9K | 0.02% | 205 |
|
|
2024
Q2 | $403K | Sell |
2,909
-311
| -10% | -$43.6K | 0.02% | 199 |
|
|
2024
Q1 | $479K | Buy |
3,220
+146
| +5% | +$19.8K | 0.02% | 204 |
|
|
2023
Q4 | $403K | Buy |
3,074
+158
| +5% | +$17K | 0.02% | 209 |
|
|
2023
Q3 | $283K | Buy |
2,916
+216
| +8% | +$23.1K | 0.01% | 232 |
|
|
2023
Q2 | $295K | Sell |
2,700
-3
| -0.1% | -$300 | 0.01% | 226 |
|
|
2023
Q1 | $260K | Hold |
2,703
| – | – | 0.01% | 233 |
|
|
2022
Q4 | $251K | Buy |
2,703
+217
| +9% | +$21.3K | 0.01% | 235 |
|
|
2022
Q3 | $229K | Buy |
2,486
+7
| +0.3% | +$745 | 0.01% | 238 |
|
|
2022
Q2 | $259K | Sell |
2,479
-212
| -8% | -$25.9K | 0.01% | 228 |
|
|
2022
Q1 | $354K | Sell |
2,691
-60
| -2% | -$8.75K | 0.02% | 207 |
|
|
2021
Q4 | $398K | Buy |
2,751
+330
| +14% | +$51K | 0.02% | 197 |
|
|
2021
Q3 | $392K | Sell |
2,421
-165
| -6% | -$26.9K | 0.02% | 174 |
|
|
2021
Q2 | $401K | Buy |
2,586
+120
| +5% | +$18.1K | 0.02% | 176 |
|
|
2021
Q1 | $314K | Buy |
2,466
+84
| +4% | +$9.9K | 0.02% | 176 |
|
|
2020
Q4 | $236K | Buy |
+2,382
| New | +$203K | 0.02% | 190 |
|
|
2020
Q3 | – | Sell |
-3,581
| Closed | -$225K | – | 217 |
|
|
2020
Q2 | $225K | Sell |
3,581
-434
| -11% | -$27K | 0.02% | 170 |
|
|
2020
Q1 | $203K | Buy |
4,015
+33
| +0.8% | +$2.9K | 0.02% | 178 |
|
|
2019
Q4 | $410K | Hold |
3,982
| – | – | 0.04% | 152 |
|
|
2019
Q3 | $363K | Sell |
3,982
-300
| -7% | -$27K | 0.03% | 166 |
|
|
2019
Q2 | $389K | Sell |
4,282
-899
| -17% | -$80.4K | 0.03% | 166 |
|
|
2019
Q1 | $424K | Sell |
5,181
-200
| -4% | -$16.3K | 0.03% | 152 |
|
|
2018
Q4 | $407K | Buy |
5,381
+500
| +10% | +$43.3K | 0.03% | 155 |
|
|
2018
Q3 | $463K | Sell |
4,881
-12
| -0.2% | -$1.17K | 0.04% | 161 |
|
|
2018
Q2 | $450K | Sell |
4,893
-752
| -13% | -$71.2K | 0.04% | 169 |
|
|
2018
Q1 | $541K | Buy |
+5,645
| New | +$562K | 0.05% | 149 |
|
|
2017
Q3 | – | Sell |
-2,479
| Closed | -$205K | – | 206 |
|
|
2017
Q2 | $205K | Buy |
+2,479
| New | +$201K | 0.02% | 198 |
|
Other funds holding COF
OIAM
EOJOAM
CNB
GIA
BC
II
Aspiriant LLC's COF Position: Q2 2026 in Review
Aspiriant LLC increased its Capital One (COF) stake by 22% in Q2 2026, buying an estimated $200K and bringing the position to 5,766 shares worth $1.16M. The position accounts for 0.03% of the portfolio, ranked #161.
Aspiriant LLC first reported a position in COF in Q2 2017 and has held it in 34 quarters since. The position peaked at $1.2M in Q4 2025. 413 funds tracked by Wall St. Rank hold COF as of Q2 2026.
- Aspiriant LLC held 5,766 shares of Capital One worth $1.16M as of Q2 2026.
- Aspiriant LLC bought 1,043 Capital One shares in Q2 2026, an estimated $200K.
- Capital One made up 0.03% of Aspiriant LLC's portfolio in Q2 2026, its #161 holding.
- Aspiriant LLC first reported a position in Capital One in Q2 2017 and has held it in 34 quarters since.
- Aspiriant LLC's Capital One position peaked at $1.2M in Q4 2025.
- 413 funds tracked by Wall St. Rank held Capital One as of Q2 2026.
Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.